DOCK11 and neoplasm: Sialic acid-binding lectins (i.e., lectins recognizing α2,3-sialic acid [MAL-I and ACG]) and α2,6-sialic acid [SNA, SSA, and TJA-I]) and a bisecting GlcNAc-binding lectin (PHA-E) were extracted for characterizing the tumor regions.